In this issue:
sNfL as a predictor of 10-year grey matter atrophy and clinical disability in MS
Efficacy and safety outcomes with DRF after switching from prior therapies or continuing on DRF
Pregnancy-induced brain MRI changes in women with MS
Oral contraceptives and disability accrual in CIS early MS
Online MS course and impact on MS knowledge and health outcomes
Yield of repeated LP for OCB analysis
T25FW is a more sensitive outcome measure than EDSS for PPMS trials
Impact of spinal cord MRI on NEDA in MS
DMTs for MS have not affected the incidence of neoplasms in clinical trials over 3 decades
Repeat infusion of autologous bone marrow cells in progressive MS
Please login below to download this issue (PDF)